Fresenius sells a majority stake in Vamed’s rehabilitation business: the advisors

Fresenius, global healthcare group, sold the majority of Vamed’s rehabilitation business to PAI Partners. Upon completion of the transaction, PAI will become the majority owner of the new company with 67 per cent, while Fresenius will retain 33 per cent. The rehabilitation business comprises 67 facilities with 9,100 beds and around 9,500 employees (FTE) across Germany, Austria, Switzerland, the Czech Republic, and the UK.

Fresenius was in-house represented with a legal team led by head of legal M&A/Transformation Jan Winzen (pictured left). Latham & Watkins LLP acted as lead counsel for Fresenius and was led by Frankfurt/Düsseldorf M&A/Private Equity partner Tobias Larisch (pictured right).

The NKF team was led by Corporate/M&A partner Patrik Peyer, working with associates Melchior Ebener and Manuel Hirlinger, junior associates Marco Sidler and Camille Stucker (all Corporate/M&A), partner Janine Reudt-Demont (Regulatory), senior associate Oliver Zbinden (Real Estate), senior associate Sven Kälin (Tax) and associate Daniela Lötscher (Employment).